Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ12761278-0,16
KB11311133-0,53
PKN93,7593,780,16
Msft-1,02
Nokia5,2845,290,53
IBM-0,48
Mercedes-Benz Group AG61,8761,90,31
PFE0,19
15.12.2025 9:27:48
Indexy online
AD Index online
select
AD Index online
 

  • 12.12.2025
West Pharm Svc (WST, NY Consolidated)
Závěr k 12.12.2025 Změna (%) Změna (USD) Objem obchodů (USD)
267,56 -1,83 -4,98 153 306 807
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 15.12.2025
Popis společnosti
Obecné informace
Název společnostiWest Pharmaceutical Services Inc
TickerWST
Kmenové akcie:Ordinary Shares
RICWST
ISIN-
Poslední známé roční výsledky31.12.2024
Poslední známé čtvrtletní výsledky30.09.2025
Počet zaměstnanců k 31.12.2024 10 600
Akcie v oběhu k 20.10.2025 71 943 412
MěnaUSD
Konstituent indexůS&P 500
Kontaktní informace
Ulice530 Herman O. West Drive
MěstoEXTON
PSČ19341
ZeměUnited States
Kontatní osobaJohn Sweeny
Funkce kontaktní osobyVice President - Investor Relations
Telefon16 105 942 900
Fax18003459800
Kontatní telefon14 847 900 373

Business Summary: West Pharmaceutical Services, Inc. is a global manufacturer that is engaged in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. The Company operates in two segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers elastomers & primary containment, drug delivery devices, integrated solutions, and analytical lab services, primarily to biologic, generic, and pharmaceutical drug customers. The Contract-Manufactured Products reportable segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. This segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.
Financial Summary: BRIEF: For the nine months ended 30 September 2025, West Pharmaceutical Services Inc revenues increased 6% to $2.27B. Net income decreased less than 1% to $361.6M. Revenues reflect Proprietary Products segment increase of 6% to $1.83B, Contract-Manufactured Products segment increase of 4% to $438.8M, Americas segment increase of 11% to $1.07B, Europe Middle East and Africa segment increase of 2% to $1.02B.
Odvětvová klasifikace
TRBC2009Medical Equipment / Supplies / Distribution
TRBC2012Medical Equipment, Supplies & Distribution (NEC)
RBSS2004Medical Equipment, Supplies & Distribution
MGINDUSTRYMedical Equipment & Supplies
MGSECTORHealthcare
NAICSSurgical and Medical Instrument Manufacturing
NAICSMedical Laboratories
NAICS2007Surgical & Medical Instrument Mfg
NAICS2007Medical Laboratories
NAICS1997Surgical and Medical Instrument Manufacturing
NAICS1997Medical Laboratories
SICSurgical And Medical Instruments
SICMedical Laboratories



  • Poslední aktualizace: 15.12.2025
Management společnosti
Data nejsou k dispozici